MTEC Archives - ATI | Advanced Technology International

11/15 2023

Inhalon Biopharma secures U.S. Army Medical Research and Development Command award to support development of inhaled therapeutics for treatment of COVID-19

2023-11-15T10:34:43-05:00November 15th, 2023|ATI in the News|

Inhalon Biopharma, a clinical-stage company advancing a proprietary inhaled antibody platform for treating acute respiratory infections (ARI), today announced that it has been awarded a $5.7 million contract by the U.S Army Medical Research and Development Command (USAMRDC) to support a U.S. Army Military Performance Advancement Initiative (MPAI) project to develop new treatments for COVID-19 and other SARS infections.

9/29 2023

Surgeons to lead multisite study of procedure to limit blood loss by partially blocking aorta

2023-10-03T08:51:18-04:00September 29th, 2023|ATI in the News|

The Partial REBOA Outcomes Multicenter Prospective Trial (PROMPT) was selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly $6 million in funding from the U.S. Department of Defense grant awarded through the Medical Technology Enterprise Consortium (MTEC).

9/27 2023

MediWound to continue developing burn treatment for US Army

2023-10-03T08:52:22-04:00September 27th, 2023|ATI in the News|

The service’s Medical Research and Development Command awarded the effort’s initial $1.7-million Defense Health Agency contract through the Medical Technology Enterprise Consortium (MTEC) the same year.

7/24 2023

OhioHealth Grant Medical Center’s trauma program joins international clinical trial

2023-07-24T14:29:21-04:00July 24th, 2023|ATI in the News|

The nearly $6 million study is being funded through the U.S. Department of Defense awarded through the Medical Technology Enterprise Consortium.

7/20 2023

MTEC members awarded to advance treatments for repeated mild traumatic brain injury
MTEC members awarded to advance treatments for repeated mild traumatic brain injury

MTEC members awarded to advance treatments for repeated mild traumatic brain injury

2023-07-14T12:29:06-04:00July 20th, 2023|Success Stories|

Astrocyte Pharmaceuticals and the University of Kentucky (partnered with Mitochon Pharmaceuticals) are working diligently to advance the development of drug treatments for repeated mild traumatic brain injury (mTBI). Each received $500,000 awards co-funded by the Medical Technology Enterprise Consortium and BrightFocus Foundation to support preclinical studies, preparation for clinical studies, and submission of an IND application.

4/4 2023

Army R&D selects biotech firm to prevent wound infection

2023-05-18T08:27:44-04:00April 4th, 2023|ATI in the News|

The award is part of the Military Prototype Advancement Initiative, funded by the Department of Defense and issued through the Medical Technology Enterprise Consortium, a collaboration of industry and academia to facilitate R&D activities with USAMRDC and other government agencies.

3/20 2023

Prytime Medical announces the launch of the PROMPT Observational Clinical Trial, the first prospective in-human study of Partial REBOA

2023-05-18T08:27:45-04:00March 20th, 2023|ATI in the News|

The PROMPT Study will give the trauma community the most compelling data yet on where Partial REBOA using pREBOA-PRO will fit in their toolkit to improve patient outcomes and save lives.

2/9 2023

Vivacelle Bio’s VBI-S Phase IIa clinical trial meets primary and secondary endpoints for treating hypovolemia in septic shock patients

2023-05-18T08:27:47-04:00February 9th, 2023|ATI in the News|

Vivacelle Bio, Inc., a privately held life science company focused on the development of treatments for hypovolemia in shock including septic shock and hemorrhagic shock, announced the successful completion of its Phase IIa clinical trial of VBI-S in septic shock patients with severe hypovolemia.

8/11 2022

Medical Innovation Challenge announces contenders for $200,000 award
Medical Innovation Challenge announces contenders for $200,000 award

Medical Innovation Challenge announces contenders for $200,000 award

2023-05-18T08:25:34-04:00August 11th, 2022|Press Releases|

Advanced Technology International (ATI) and TechConnect today announced 25 finalists who will pitch on September 28, 2022 at Defense TechConnect Innovation Summit for $200,000 in non-dilutive awards. These candidates receive membership from four consortia with a combined $50B in federal contracting authority including: Medical CBRN Defense Consortium (MCDC), Countering Weapons of Mass Destruction Consortium (CWMD), Medical Technology Enterprise Consortium (MTEC), and Senior Healthcare Innovation Consortium (SHIC).

6/21 2022

Army asks industry to develop handheld sensor to help care for military burn victims on the front lines

2023-05-18T08:25:49-04:00June 21st, 2022|ATI in the News|

This handheld device is for Army battalion aid stations, brigade support aid stations,and field hospitals for triaging and evacuation decision making. Officials of the Medical Technology Enterprise Consortium (MTEC) in Summerville, S.C., issued a request for project proposals (MTEC-22-08-BDA) on Friday for the Burn Digital Assessment project.